sickle

Sickle-cell disease targeted by CRISPR in potential first human application

Daily Californian | 
The breakthrough gene-editing technology CRISPR-Cas9, which was co-discovered by Jennifer Doudna, a UC Berkeley professor of biochemistry and molecular biology, may soon be ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists